Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
VIJAYA | NSE
36.05
3.50%
Healthcare
Diagnostics & Research
31/03/2024
24/04/2026
1,065.55
1,039.45
1,070.00
1,005.00
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. It offers laboratory services including clinical biochemistry haematology and immuno-haematology clinical pathology histopathology and cytopathology microbiology serology cytogenetics and molecular pathology; radiology and imaging services comprising magnetic resonance imaging multi slice CT CBCT (3D dental) mammography DEXA/bone densitometry ultrasound/color doppler nuclear medicine and PET/CT and digital X-ray; and cardiology neurology and gastroenterology services. The company also provides health checkups and home sample collection services. It operates through a network of 95 diagnostic centers and 1 national reference laboratory as well as 11 reference laboratories across 15 cities in the states of Telangana Andhra Pradesh West Bengal and the NCR. The company was incorporated in 1981 and is based in Hyderabad India.
View LessPositive Momentum
Strength based on increasing price with high volume
Low 6-Month Volatility (<30%)
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
Smallcap (300M - 2B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
20.5%1 month
25.9%3 months
27.4%6 months
27.4%81.28
-
16.31
0.39
0.26
45.44
19.72
-
2.34B
108.18B
1.13B
0.10
28.55
19.10
29.10
19.83
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
115.85
Range1M
222.00
Range3M
222.00
Rel. volume
3.06
Price X volume
456.33M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Dr. Lal PathLabs Limited | LALPATHLAB | Diagnostics & Research | 1408.9 | 117.36B | -1.54% | 72.99 | 13.35% |
| METROPOLIS | METROPOLIS | Diagnostics & Research | 467.1 | 23.90B | -1.08% | 82.96 | 17.98% |
| Thyrocare Technologies Limited | THYROCARE | Diagnostics & Research | 395.1 | 20.92B | -0.01% | 59.87 | 8.04% |
| Krsnaa Diagnostics Limited | KRSNAA | Diagnostics & Research | 601.05 | 19.23B | -1.70% | 44.93 | 19.73% |
| Vimta Labs Limited | VIMTALABS | Diagnostics & Research | 457.65 | 9.99B | -3.17% | 30.20 | 6.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Honasa Consumer Limited | HONASA | IN | 348.85 | 117.21B | 0.81% | 108.44 | 11.96% |
| Azad Engineering Limited | AZAD | IN | 2090.2 | 117.16B | -0.99% | 130.37 | 6.11% |
| SANOFI CONS HEALTHC IND L | SANOFICONR | IN | 4595.3 | 113.17B | 0.12% | n/a | |
| Vedant Fashions Limited | MANYAVAR | Apparel Retail | 450.05 | 110.08B | -2.65% | 84.26 | 27.74% |
| Cello World Limited | CELLO | IN | 427.45 | 94.42B | 1.16% | 54.80 | 32.26% |
| INDIA SHELTER FINANCE CORPORATION LIMITED | INDIASHLTR | IN | 809.7 | 90.17B | 0.47% | 27.80 | 148.57% |
| KIRLOSKAR PNEUMATIC CO LTD | KIRLPNU | IN | 1337.4 | 86.72B | 0.70% | 65.64 | 0.08% |
| Akums Drugs and Pharmaceutical | AKUMS | IN | 514.3 | 73.99B | -4.67% | 10.40K | |
| AVALON TECHNOLOGIES LTD | AVALON | IN | 1040.65 | 68.67B | -4.40% | 210.84 | 38.11% |
| Ceigall India | CEIGALL | IN | 326.2 | 57.58B | 0.43% | 21.90 |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 45.44 | 22.78 | Expensive |
| Ent. to Revenue | 19.72 | 6.55 | Expensive |
| PE Ratio | 81.28 | 51.14 | Expensive |
| Price to Book | 16.31 | 6.69 | Expensive |
| Dividend Yield | 0.10 | 0.94 | Poor |
| Std. Deviation (3M) | 27.37 | 32.84 | Par |
| Debt to Equity | 0.39 | 0.18 | Expensive |
| Debt to Assets | 0.26 | 0.12 | Expensive |
| Market Cap | 108.18B | 60.74B | Market Leader |